iBio Inc (NASDAQ: IBIO) kicked off on Friday, down -19.83% from the previous trading day, before settling in for the closing price of $2.42. Over the past 52 weeks, IBIO has traded in a range of $0.56-$6.89.
A company in the Healthcare sector has jumped its sales by 64.37% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 84.57%. With a float of $21.87 million, this company’s outstanding shares have now reached $22.49 million.
iBio Inc (IBIO) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of iBio Inc is 2.74%, while institutional ownership is 25.62%. The most recent insider transaction that took place on Jan 10 ’25, was worth 25,000. In this transaction Chief Financial Officer of this company bought 9,191 shares at a rate of $2.72, taking the stock ownership to the 11,139 shares. Before that another transaction happened on Jan 10 ’25, when Company’s insider bought 9,191 for $2.72, making the entire transaction worth $25,000. This insider now owns 18,316 shares in total.
iBio Inc (IBIO) Latest Financial update
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.48 earnings per share (EPS), lower than consensus estimate (set at -0.46) by -0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.06 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 84.57% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 43.84% during the next five years compared to 64.37% growth over the previous five years of trading.
iBio Inc (NASDAQ: IBIO) Trading Performance Indicators
Take a look at iBio Inc’s (IBIO) current performance indicators. Last quarter, stock had a quick ratio of 8.39. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 87.26.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.39, a number that is poised to hit -0.07 in the next quarter and is forecasted to reach -0.23 in one year’s time.
Technical Analysis of iBio Inc (IBIO)
Let’s dig in a bit further. During the last 5-days, its volume was 49.38 million. That was better than the volume of 2.95 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 49.65%.
During the past 100 days, iBio Inc’s (IBIO) raw stochastic average was set at 42.40%, which indicates a significant increase from 33.80% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.3674 in the past 14 days, which was higher than the 0.1379 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.2582, while its 200-day Moving Average is $1.4660. However, in the short run, iBio Inc’s stock first resistance to watch stands at $2.2667. Second resistance stands at $2.5933. The third major resistance level sits at $2.8117. If the price goes on to break the first support level at $1.7217, it is likely to go to the next support level at $1.5033. The third support level lies at $1.1767 if the price breaches the second support level.
iBio Inc (NASDAQ: IBIO) Key Stats
The company with the Market Capitalisation of 43.63 million has total of 22,487K Shares Outstanding. Its annual sales at the moment are 400 K in contrast with the sum of -18,380 K annual income. Company’s last quarter sales were recorded 100 K and last quarter income was -5,720 K.
